Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer

This study has been terminated.
(Slow Accrual.)
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00103090
First received: February 7, 2005
Last updated: November 12, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2006
  Primary Completion Date: January 2006 (Final data collection date for primary outcome measure)